Mithra Pharmaceuticals S.A.
A biotech company developing drugs for contraception, fertility, and menopause.
MITRA | BR
Overview
Corporate Details
- ISIN(s):
- BE0974283153 (+1 more)
- LEI:
- 5493002FDD273HTEKK14
- Country:
- Belgium
- Address:
- Rue Saint-Georges 5, 4000 Liège
- Website:
- https://www.mithra.com/
- Sector:
- Manufacturing
Description
Mithra Pharmaceuticals S.A. is a biotech company dedicated to women's health. The company focuses on the development, manufacturing, and commercialization of differentiated drugs and complex therapeutic solutions. Its core areas of expertise include contraception, fertility, and menopause. Mithra aims to transform the women's health sector by providing innovative choices to support and improve the overall quality of life for women.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-12-10 08:00 |
Mithra launches an offering of up to EUR 150 million convertible bonds due 2025
|
English | 178.3 KB | ||
| 2020-12-10 08:00 |
Mithra lance une offre d'obligations convertibles d'un montant maximum de EUR 1…
|
French | 187.5 KB | ||
| 2020-12-08 07:30 |
3. 2020-12-08 MITHRA - Rapport CA (ENG) (1).pdf
|
English | 1.1 MB | ||
| 2020-11-20 17:45 |
2020-11-20-Attestation notariale.pdf
|
French | 351.2 KB | ||
| 2020-11-20 17:45 |
Creation of a New Share Option Plan in Replacement of the 2018 Share Option Plan
|
English | 137.6 KB | ||
| 2020-11-20 17:45 |
Création d’un nouveau Plan de Droits de Souscription en Remplacement du Plan de…
|
French | 140.9 KB | ||
| 2020-11-20 07:30 |
4. 2020.11.20 Share Options Plan - Signed Board Report.pdf
|
English | 813.8 KB | ||
| 2020-11-03 07:30 |
Mithra Renews its Board of Directors to Support its Operational Ambitions
|
English | 160.8 KB | ||
| 2020-11-03 07:30 |
Mithra renouvelle son Conseil d’administration pour appuyer ses ambitions opéra…
|
French | 208.6 KB | ||
| 2020-10-06 07:30 |
Mithra Announces FDA update
|
English | 164.6 KB | ||
| 2020-10-06 07:30 |
Mithra annonce un update de la FDA
|
French | 169.3 KB | ||
| 2020-09-24 07:30 |
Mithra Announces 2020 Half Year Results
|
English | 289.4 KB | ||
| 2020-09-24 07:30 |
Mithra annonce ses résultats semestriels 2020
|
French | 280.1 KB | ||
| 2020-09-24 07:30 |
2020-09-24-First half 2020 financial report-EN.pdf
|
English | 691.0 KB | ||
| 2020-09-24 07:30 |
2020-09-24-First half 2020 financial report FR.pdf
|
French | 801.3 KB |
Automate Your Workflow. Get a real-time feed of all Mithra Pharmaceuticals S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Mithra Pharmaceuticals S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Mithra Pharmaceuticals S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-01-17 | NOSHAQ SA | Board | Other | 172,574 | 617,814.92 EUR |
| 2022-11-17 | NOSHAQ SA | Board | Other | 172,574 | 1,052,701.40 EUR |
| 2022-07-18 | NOSHAQ SA | Board | Other | 156,250 | 1,006,250.00 EUR |
| 2022-05-13 | NOSHAQ SA | Board | Other | 156,250 | 1,239,062.50 EUR |
| 2022-04-13 | Gordenne Valérie | Other | Sell | 8,500 | 87,380.00 EUR |
| 2022-03-29 | Fornieri Francesco | Board | Sell | 100,000 | 1,312,000.00 EUR |
| 2022-03-25 | Fornieri Francesco | Board | Sell | 35,893 | 486,530.57 EUR |
| 2022-03-24 | Fornieri Francesco | Board | Sell | 15,657 | 219,536.19 EUR |
| 2022-03-24 | Fornieri Francesco | Board | Sell | 2,818 | 39,452.00 EUR |
| 2022-03-23 | Fornieri Francesco | Board | Sell | 12,525 | 178,230.75 EUR |
Peer Companies
